Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com
Looking for a particular NovAliX employee's phone or email?
The NovAliX annual revenue was $90.9 million in 2026.
Denis Zeyer is the CEO of NovAliX.
298 people are employed at NovAliX.
NovAliX is based in Strasbourg, Grand Est.